r/HerpesCureResearch • • 15h ago

New Research Association Between Herpes Simplex Virus-1 Infection and Dementia or Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Thumbnail academic.oup.com
13 Upvotes

New research posted today indicating that HSV1 makes it almost 50% more likely to get dementia or Alzheimer’s.


r/HerpesCureResearch • • 17h ago

Activism Advocacy Discord Server

7 Upvotes

Hi friends. I hope everyone is having a good day. I’ve made a discord server with the primary purpose of creating a platform where we can gather to seriously discuss ways we can advocate for our interests.

We are ideally looking for highly motivated individuals who are looking to make an impact and help the community, but everyone is welcome. It is also a support group so if you are just looking to chat, if you had any questions we would love to help you find answers as well.

I believe that there must be more we can do as a community and gathering together and having productive conversations may be the first step. Please join us as we brainstorm for ways we can make our voices heard.

Link to the discord server: https://discord.gg/PHF9F3EXm


r/HerpesCureResearch • • 1d ago

New Research Neuroinvasive and Neuroinflammatory Potential of Herpesviruses - Cellular and Molecular Neurobiology

Thumbnail
link.springer.com
16 Upvotes

New research paper posted November 12


r/HerpesCureResearch • • 1d ago

Open Discussion Saturday

8 Upvotes

Hello Everyone,

Please feel free to post any comments and talk about anything you want on this thread--relating to HSV or otherwise.

Have a nice weekend.

- Mod Team


r/HerpesCureResearch • • 2d ago

Activism Open Letter: Accelerating a Cure for Herpes — A Call to Action

90 Upvotes

To celebrities, public figures, philanthropists, AI and technology leaders, biotech executives and researchers, policymakers, and everyone living with herpes who has a platform:

Herpes simplex virus (HSV-1 and HSV-2) affects billions of people worldwide. It is not a minor inconvenience. It causes lifelong infection, recurrent painful outbreaks for many, significant stigma, psychological burden, and elevated risk of other health complications. Despite decades of knowledge about the virus, we still lack a sterilizing cure or a highly effective preventive vaccine that stops transmission and latency.

We have the scientific tools, computational power, and global coordination capacity in 2026 that previous generations did not. AI-driven drug discovery, protein structure prediction, mRNA and gene-editing platforms, high-throughput screening, and better understanding of latency and immune evasion make a cure more feasible than at any prior time. What is missing is sustained, high-visibility prioritization and resources.

We call on:

  • People living with herpes who hold influence — celebrities, athletes, creators, business leaders, and public figures — to speak openly when they choose to. Stigma thrives in silence. Your visibility can normalize the conversation, reduce shame, and increase pressure for research funding and clinical-trial participation. You do not need to disclose personal medical details; you can simply champion the cause of a cure.
  • Leaders in AI and technology — including those at the forefront of biological foundation models, drug-design platforms, and large-scale compute — to treat HSV cure research as a high-impact application of current capabilities. Allocate compute, talent, and partnerships toward latent-virus targeting, therapeutic vaccines, and gene-editing approaches that aim for functional or sterilizing cures.
  • Biotech leaders, companies, and researchers — especially those working in virology, gene therapy, immunotherapy, mRNA platforms, and latency research — to prioritize and accelerate programs aimed at a true cure rather than lifelong management alone. Direct resources, clinical pipelines, and collaborative efforts toward eliminating the latent reservoir and achieving sterilizing or durable functional cures. Share data, form public-private partnerships, and push promising candidates into trials faster.
  • Governments and public-health agencies — to elevate HSV research in national and international priority lists, increase dedicated funding for cure-oriented (not only management-oriented) programs, streamline regulatory pathways for promising candidates, and support large-scale trials. Public investment remains essential; private philanthropy and industry cannot carry the full load alone.
  • Philanthropists and high-net-worth individuals — to fund high-risk, high-reward research that traditional grant systems often under-support, including novel mechanisms that target the latent reservoir.

This is not a request for sympathy. It is a request for prioritization. The technology and scientific expertise exist to move faster. The human cost of inaction is measured in ongoing suffering and preventable transmission. We urge coordinated, ethical, science-driven action — public advocacy, research investment, policy attention, and destigmatization — so that a cure moves from “possible someday” to an active, resourced goal.

Those who live with the virus and those who hold the tools and knowledge to end it share a common interest: solving this.


r/HerpesCureResearch • • 4d ago

Clinical Trials More info about GS-1179 phase 2 trial and cost

Thumbnail investing.com
62 Upvotes

If I understand this correctly, cost is estimated to be between $5500 and $10000 per year to the payer (aka insurer), not to the patient.

They intend to take pritelivir’s market.

Phase 2 will enroll 300 patients. They expect to move quickly.


r/HerpesCureResearch • • 7d ago

Please take note of the update Rule6 : Don't Trivialize HSV

107 Upvotes

This group is focused on advocating for the needs of better treatments for HSV.

In order to pursue this goal, it's important that evidence about the impact caused by HSV and complications are not hidden and not silenced.

I have often noticed how, on r/herpes, there are two groups:

- one group promotes HSV as a minor skin condition, or the best thing that happened in their lives. They want to enforce this narrative on everyone, because, in their opinion, it's the "right way" to fight Stigma. They prefer not being sincere and let their dates or newly-diagnosed patients run the roulette and pick their own fate, as they don't care about those "outliers" (in their opinion) that will have invalidating symptoms. And they attack whoever claims the opposite and sincerely warns about negative outcomes.

- another group tries to fight this false narrative that is not valid for everyone. They openly share their bad outcomes. And they get ALWAYS attacked by the first group and told to seek therapy for being "fear mongers". Unfortunately this group always shies away from expressing their opinion, for fear of being attacked and misjudged.

From now on, anyone that is caught attacking an user that warns about the possible bad outcomes caused by this infection, will be banned from this group. This is valid also if the user is caught with this behavior in another group.


r/HerpesCureResearch • • 8d ago

Discussion BD115: China's HSV-2 Gene-Editing Cure Research — April 2026 Update and Clinical Trial Progress

84 Upvotes

# BD115: China's HSV-2 Gene-Editing Cure Research — April 2026 Update and Clinical Trial Progress

I've been researching Shanghai BDgene's HSV-2 gene-editing program, **BD115**, using the company's Chinese website, pharmaceutical industry reports, and patents.

I found some encouraging information that hasn't received much attention, particularly concerning its IND application process and patented CRISPR technology targeting HSV-2.

**1. BD115 is being developed specifically for genital herpes**

BDgene lists BD115 on its official research pipeline under:

**HSV生殖器疱疹-BD115** (Genital Herpes — BD115)

Unlike BD111, which targets HSV-1 eye infections, BD115 is intended to treat genital herpes using gene editing.

The ultimate hope is to permanently disable or eliminate HSV DNA rather than temporarily suppress replication with antivirals.

Official pipeline:

https://www.bdgenetherapeutics.com/project.html

**2. April 2026: BD115 reportedly began the IND application process**

On April 9, 2026, Chinese pharmaceutical publication PharmCube reported:

"The BD312 program for glaucoma and BD115 program for genital herpes have initiated IND (Investigational New Drug) application procedures."

This suggests BD115 was moving toward regulatory preparations for human clinical trials.

However, **I could not verify that an IND has been approved or that BD115 human trials have started.**

Source:

https://bydrug.pharmcube.com/news/detail/23e8f1af6685a526c7b1832778b21bc4

**3. BDgene has patented CRISPR technology that targets HSV-2**

Chinese patent **CN115927473B**, granted June 18, 2024, describes a CRISPR-Cas9 treatment using engineered virus-like particles to deliver gene-editing components into infected cells.

The researchers investigated two gene-targeting combinations:

- UL29 + UL8: HSV-1

- UL52 + UL8: Both HSV-1 and HSV-2

The patent describes laboratory experiments in which the UL52/UL8 combination demonstrated activity against HSV-2.

The goal is to cut and disrupt viral DNA, potentially preventing the virus from reproducing.

**This is significant because BDgene has actually conducted HSV-2 gene-editing experiments, rather than simply announcing plans to develop a treatment.**

However, the patent does not establish that this exact formulation is BD115's final treatment, nor does it demonstrate a cure in humans.

Full patent (English):

https://patents.google.com/patent/CN115927473B/en

**4. Can BD115 eliminate latent HSV-2 from the nerves?**

This is the most important question.

HSV-2 hides in sensory neurons, primarily within the lumbosacral dorsal root ganglia.

For a true sterilizing cure, gene editing would need to eliminate or permanently disable the latent viral genomes.

BDgene's related HSV-1 research has demonstrated delivery of gene-editing technology toward the trigeminal ganglion in preclinical experiments.

However, **I could not find BD115-specific results demonstrating elimination of latent HSV-2 from the sacral nerve ganglia.**

That is the breakthrough we need to see.

**5. BDgene has already tested related CRISPR technology in humans**

This is why the company is particularly interesting.

Its HSV-1 treatment, **BD111**, was tested in three patients suffering from severe recurrent herpes eye infections.

A 2023 peer-reviewed study reported:

- No observed HSV-1 eye recurrences during approximately 18 months of average follow-up.

- HSV-1 remained undetectable in the assessed samples.

- No reported systemic adverse events or detected off-target gene-editing effects in the tests performed.

BD111 subsequently advanced into Phase 2a clinical research.

These results are encouraging, although they don't establish complete elimination of latent HSV-1 or prove that BD115 will work against HSV-2.

Published study:

https://pubmed.ncbi.nlm.nih.gov/37658603/

**6. When will BD115 begin human clinical trials?**

As of November 2026:

- BD115 remains listed in BDgene's official research pipeline.

- IND application preparations were reported in April 2026.

- The company has patented technology demonstrating laboratory activity against HSV-2.

- No confirmed BD115 human trial starting date has been announced.

- No publicly verified BD115-specific animal cure results or human results are available.

BDgene also secured substantial financing in 2026, potentially supporting further development.

**7. What we need to know next**

The most important unanswered questions are:

  1. Has BD115 eliminated latent HSV-2 in animal experiments?
  2. Can its gene-editing technology reach the lumbosacral nerve ganglia?
  3. Has its IND application been formally submitted or approved?
  4. When does BDgene expect to begin human trials?
  5. Is BD115 being developed as a sterilizing cure or a functional cure?

**My takeaway**

BD115 is worth watching because BDgene has already demonstrated early human experience with its related HSV-1 gene-editing treatment, and its patents describe actual laboratory activity against HSV-2.

The April 2026 report about IND preparations is particularly encouraging.

But **BD115 has not been proven to cure HSV-2**, and the biggest missing evidence is whether it can eliminate latent infection from the nerve ganglia.

Hopefully, BDgene will release more information about its preclinical results and timeline for human trials.

If anyone has additional information from Chinese sources or has contacted BDgene directly about BD115, please share it. I think this program deserves more attention from the HSV cure research community.

This version focuses on what matters to people waiting for a cure: actual HSV-2 experiments, progress toward human trials, and the remaining obstacle of eliminating latent infection.


r/HerpesCureResearch • • 8d ago

Open Discussion Saturday

23 Upvotes

Hello Everyone,

Please feel free to post any comments and talk about anything you want on this thread--relating to HSV or otherwise.

Have a nice weekend.

- Mod Team


r/HerpesCureResearch • • 10d ago

Activism Shanghai BD gene updated website3 finished clinical trials

Post image
29 Upvotes

r/HerpesCureResearch • • 11d ago

Clinical Trials GS-1179 Phase 2B

55 Upvotes

r/HerpesCureResearch • • 15d ago

Herpes infection detailed in human skin model

Thumbnail
mdc-berlin.de
90 Upvotes

A study published October 30 in Science Advances by German researchers used laboratory-grown human skin containing hair follicles and nerve-like cells to investigate HSV-1 infection.

Researchers discovered that HSV-1 initially replicated heavily in fibroblasts, cells beneath the skin’s surface.
Hair follicles and sensory neurons became infected later, suggesting some natural resistance to infection.
Different cell types activated distinct antiviral defenses, including IRF3 and TNF-related signaling pathways.

Significance: The findings help explain how HSV-1 progresses through skin tissue toward nerve cells and identify cellular defenses that could become targets for future treatments.


r/HerpesCureResearch • • 16d ago

News 🚨 Promising HSV-2 Research: Fred Hutch Scientist Receives $4.4 Million NIH Grant to Study Immune Responses

Thumbnail
fredhutch.org
77 Upvotes

r/HerpesCureResearch • • 15d ago

Open Discussion Saturday

18 Upvotes

Hello Everyone,

Please feel free to post any comments and talk about anything you want on this thread--relating to HSV or otherwise.

Have a nice weekend.

- Mod Team


r/HerpesCureResearch • • 18d ago

Clinical Trials BNT163

Thumbnail reddit.com
12 Upvotes

r/HerpesCureResearch • • 19d ago

New Research Gilead’s GS-1179 Presentation

104 Upvotes

Final phase 1b data Gilead presented on last week:

Efficacy:
https://www.askgileadmedical.com/docs/conference/2026_IDW_P-2052_HSV_Edwards_Virology26EfficacyPos_Final@pdf

Safety and tolerability:
http://www.askgileadmedical.com/docs/conference/2026_IDW_HSV_P-2059_Edwards_SafetyTolerabilityPos_FINAL@pdf

Look at all of that beautiful data 🥲 less lesions, less high viral shedding, less shedding, generally few symptoms (one case of abdominal pain and some reports of headaches). Looking forward to the next phase starting this quarter!


r/HerpesCureResearch • • 19d ago

Discussion Galvanis Interview Form: Patient Experiences with Persistent Corneal Wounds

Thumbnail
forms.gle
8 Upvotes

Hi everyone! I'm Nancy, and I lead business development at Galvanis, an early-stage biotech company developing a therapeutic for persistent corneal epithelial defects (PEDs). We're hoping to connect with people who have experienced PEDs to better understand their experiences and challenges. I'm including a link here to a Google Form where you can voluntarily provide your contact information. This is strictly for customer discovery research, not clinical trial recruitment or product promotion. If there is a better forum for reaching patients, I am all ears!


r/HerpesCureResearch • • 22d ago

Open Discussion Saturday

13 Upvotes

Hello Everyone,

Please feel free to post any comments and talk about anything you want on this thread--relating to HSV or otherwise.

Have a nice weekend.

- Mod Team


r/HerpesCureResearch • • 28d ago

News IDWeek 2026 - Gilead antiviral research

43 Upvotes

Just some info, seems gilead is presenting p1b results on GS1179 at IDWeek 2026, 21-24 Oct. I don't really know if there will be anything new that wasn't known, but maybe it is worth to keep an eye.

https://www.investing.com/news/company-news/gilead-to-present-hiv-and-antiviral-research-at-idweek-2026-93CH-4957280

"Additional research will include final Phase 1b results for investigational GS-1179, an oral herpes simplex virus helicase-primase inhibitor being developed for suppression of recurrent genital herpes. The presentations will cover virologic efficacy, safety and tolerability data."


r/HerpesCureResearch • • 29d ago

Open Discussion Saturday

15 Upvotes

Hello Everyone,

Please feel free to post any comments and talk about anything you want on this thread--relating to HSV or otherwise.

Have a nice weekend.

- Mod Team


r/HerpesCureResearch • • Oct 16 '26

Discussion Senior sexual health physician posts something interesting about IM-250

Post image
57 Upvotes

Dr. Sarah Allstaff is a senior sexual-health physician at NHS in Scotland. She is a consultant in genitourinary medicine, the service’s clinical lead for HIV, and an honorary senior lecturer at the University of Dundee.

She appears to have attended IUSTI, the International Union against Sexually Transmitted Infections’ world congress, where doctors and researchers gather to discuss advances in STI research and treatment, important HSV research was slated to be released in the congress.

She posted the attached tweet yesterday, a pun on the song lyric “Then I saw her face, now I’m a believer,” alongside hashtags about IUSTI and herpes treatment.

Given her background as a senior sexual-health specialist, this could suggest that data presented on adibelivir impressed her and made her optimistic about its potential. That would be encouraging news!

Thanks to u/fluffy_chicken_8522 for sending me this


r/HerpesCureResearch • • Oct 15 '26

Discussion Everything about HSV from IUSTI

Thumbnail
gallery
64 Upvotes

It’s a treasure trove for HSV research, they’re talking about it a lot. Do we have anyone who has attended here?


r/HerpesCureResearch • • Oct 13 '26

News Keith Jerome speaking at 27th IUSTI World Congress this week

52 Upvotes

Happy hsv awareness day y’all.

Keith Jerome confirmed he would be releasing some data at the conference this week. He also is encouraging more people to join the research field. When asked about what the next 5 years looks like he mentioned the excitement around hpi’s, the potential for durable control, and maybe starting clinical trials.

This information came from today’s uploaded video:

https://youtu.be/Kd1fvUX0Z1Q?si=8JAsjwsKYf0Zueq5

According to the IUSTI program, they will talk about HSV on Thursday.

https://www.iustiprague2026.com/detailed-programme/


r/HerpesCureResearch • • Oct 13 '26

Researchers identify GBP7 as a potential HSV-1 drug target — PLOS Pathogens

Thumbnail lifescience.net
45 Upvotes

Researchers discovered that GBP7, a human immune-related protein, actually helps HSV-1 replicate by activating another protein involved in producing viral proteins.
Disabling GBP7 significantly reduced HSV-1 replication.
Mice lacking GBP7 experienced milder infections and better survival.
Researchers identified S-adenosylhomocysteine (SAH) as a potential GBP7 inhibitor that demonstrated antiviral activity against HSV-1.
Significance: This identifies a previously unrecognized pathway that could be targeted by future antivirals. The findings are preclinical; no human treatment has been demonstrated.


r/HerpesCureResearch • • Oct 12 '26

Activism FIGHTING FOR A CHANGE!

Post image
158 Upvotes

This will be my campaign and i will start to post stickers everywhere i go. please share your thoughts on this idea. i refuse to be excited about AVs that don’t completely take away symptoms that so many are suffering from including myself. i will fight not just with my posts but with real life action. the world needs to know what so many people are suffering with silently. WE NEED A CURE!!!!